BTXBrooklyn ImmunoTherapeutics, Inc.

NYSE · US · Healthcare · Asset Management

9.010USD+1.46%Mkt Cap: 1.05B $P/E: 24.353d ago

BlackRock Technology and Private Equity Term Trust is a mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. BlackRock Technology and Private Equity Term Trust is domiciled in the Unite…

Industry Peers

Asset Management

Brookfield Corporation Class A Limited Voting Shares

$93.07BUSDP/E 77.2

BAM

BROOKFIELD ASSET MANAGEMENT INC

$83.54BUSDP/E 30.1

APO

Apollo Global Management, Inc.

$78.36BUSDP/E 47.2

STT

State Street Corporation

$51.40BUSDP/E 16.5

AMP

Ameriprise Financial, Inc.

$49.11BUSDP/E 13.4

ARES

Ares Management Corporation

Raymond James Financial, Inc.

$33.70BUSDP/E 15.3

NTRS

Northern Trust Corporation

$33.65BUSDP/E 15.7

OWL

Blue Owl Capital Inc. Class A Common Stock

$28.50BUSDP/E 97.3

INDU-A

AB Industrivarden (publ)

$21.96BUSDP/E 3.7

INDU-C

AB Industrivarden (publ)

$21.81BUSDP/E 3.6

TROW

T. Rowe Price Group, Inc.

$23.79BUSDP/E 11.2

PFG

Principal Financial Group, Inc.

$23.71BUSDP/E 15.8

PGHN

Partners Group Holding AG

Key Statistics

Company

Market Cap1.05B $

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)8.69M $

Revenue/Share—

Last Price9.010 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

SectorHealthcare

IndustryAsset Management

ISIN—

Valuation

P/E (Trailing)24.35

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B—

EPS (TTM)0.37

EPS (Forward)—

52W Range

6.13087% of range9.435

52W High9.435 USD

52W Low6.130 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin75.65%

ROE0.95%

ROA0.93%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF877.82M $

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh—

Cash/Share—

Dividends

Fwd Div Rate0.6300 USD

Trail. Div Rate0.0000 USD

Div. Yield7.09%

5Y Avg Yield—

Payout Ratio243.64%

Ex-Div DateSep 15, 2026

Pay DateSep 30, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.116.71M

Float—

Insiders0.00%

Institutions29.48%

Short Interest

Short Ratio0.3d

Short % Out.0.18%

Shares Short249.64K

Short (prev mo.)172.57K

Technical

SMA 508.636 (+4.3%)

SMA 2007.493 (+20.2%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)599.73K

Avg Vol (10d)498.40K

Technical Indicators

RSI (14)58.8

MACD0.1615

MACD Signal0.0730

MACD Hist.+0.0885

BB Upper9.388 USD

BB Middle8.488 USD

BB Lower7.588 USD

BB Width21.20%

ATR (14)0.2737 USD

Vol Ratio (20d)0.59x